CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma announces pricing of its IPO of 5,580,000 shares of common stock at a public offering price of $15/share. Underwriters granted an option to purchase up to 837,000 additional shares....
More...
More Articles...
- SHAREHOLDER ALERT: Law Office of Brodsky Smith, LLC Announces Investigation of Cornerstone Therapeutics, Inc.
- Allied Systems Holdings Obtains Court Approval of Sale to Jack Cooper Holdings
- Glancy Binkow Goldberg LLP Announces Investigation on Behalf of Shareholders of Chemed Corporation
- Fitch Affirms BALL 2009-FDG
- Activision Blizzard Remains Committed to Transaction with Vivendi
- Garrison Capital Inc. Announces Pricing of Credit Facility Refinance
- Fitch Releases Report on Florida Keys Aqueduct Authority, FL
- Harsco's Affirms Harsco's IDR at 'BBB-'; Outlook Negative
- Research and Markets: Ammonium Nitrate (AN): 2013 World Market Outlook and Forecast up to 2017
- Research and Markets: Global Market for Road Rollers, Tamping and Compacting Machines to 2017 - Market Size, Growth and Forecasts in Over 60 Countries
Page 55740 of 56328
- Magazine seeks writers for online column in U.S.A, U.K., Asia & Australia. Writers wanted
- Hunt for Queen's Wharf developer commences
- Queensland unit and townhouse sales climb
- Perth median house price at new record
- Don’t let a bad credit score ruin your chances of a home loan
- The Importance of Communication for Business Success
- Businesses
- Respected local restaurateurs are the icing on the Tweed River Art Gallery
- Lonely Planet names Kimberley as world’s second top tourism region for 2014
- The Workers Launch Balmain's Biggest Laugh Free Live Comedy
- UK Innovator Visa: Getting Endorsement
- Surplus signals time for NSW Government to cut stamp duty
- Jazz Degustation + The Cellar Jazz Jam
- Katter calls for better delivery of drought assistance
- The Global Forest Industry This Quarter
- Record harvest ensures city fruit and veg supplies
